Addiction News and Research

RSS

Weight loss drug semaglutide proven safe and effective for people with schizophrenia

Diabetic weight loss medications are effective for people with schizophrenia without affecting psychotic symptoms, University of Queensland researchers have found.

10 Jun 2025

Dr. Stephen Ross’s research into psychedelic medicine expands therapeutic frontiers

In a comprehensive Genomic Press Interview published today, Dr. Stephen Ross, a leading figure in psychedelic medicine at New York University (NYU), reveals how a serendipitous conversation in 2006 launched his journey into investigating psychedelic compounds as potential breakthrough treatments for some of psychiatry's most challenging conditions.

10 Jun 2025

As federal health grants shrink, memory cafes help dementia patients and their caregivers

Rob Kennedy mingled with about a dozen other people in a community space in Clarks Summit, Pennsylvania.

10 Jun 2025

Study links reelin to cocaine-induced brain and behavior changes

Cocaine, a drug of abuse, activates just a portion - 10 to 20 percent - of the neurons in the brain's nucleus accumbens, a critical region linked to motivation and addiction.

9 Jun 2025

As cannabis users age, health risks appear to grow

Benjamin Han, a geriatrician and addiction medicine specialist at the University of California-San Diego, tells his students a cautionary tale about a 76-year-old patient who, like many older people, struggled with insomnia.

9 Jun 2025

Teens who smoke or vape are more likely to use cannabis, study finds

German adolescents who use cigarettes or e-cigarettes are at higher risk for cannabis use, underscoring the need for effective school-based prevention programs.

5 Jun 2025

Fruit fly model sheds light on genetic roots of cocaine addiction

In a new JNeurosci paper, Adrian Rothenfluh and colleagues from the University of Utah developed a fruit fly model of cocaine self-administration that can be used to explore the genetic underpinnings of cocaine addiction.

3 Jun 2025

Asthma drug once hoped to treat alcohol use disorder fails to meet expectations in UCLA trial

A drug that once showed promise as a treatment for alcohol use disorder did not work as expected, a new UCLA clinical trial found.

3 Jun 2025

Health harm warnings found most effective in discouraging e-cigarette use

Electronic-cigarette warnings are effective in discouraging vaping, with warnings specific to health harms being generally more effective than warnings about e-cigarette addiction, according to a meta-analysis of 24 studies conducted by University of North Carolina Lineberger Comprehensive Cancer Center researchers and their colleagues.

2 Jun 2025

Researchers show cannabis dependence drives links to psychiatric disorders

Research uncovers genetic connections between cannabis addiction and psychiatric disorders, urging a reevaluation of cannabis legalization and treatment.

2 Jun 2025

New genetically modified fruit fly model sheds light on cocaine addiction

For the first time, researchers have created genetically modified fruit flies that can become addicted to cocaine.

2 Jun 2025

WHO calls on governments to ban flavors in all nicotine products

On World No Tobacco Day, the World Health Organization (WHO) today launches a new publication and calls on governments to urgently ban all flavors in tobacco and nicotine products, including cigarettes, pouches, hookahs and e-cigarettes to protect youth from addiction and disease.

30 May 2025

WHO urges global ban on flavored tobacco and nicotine products

On World No Tobacco Day, the World Health Organization (WHO) today launches a new publication and calls on governments to urgently ban all flavours in tobacco and nicotine products, including cigarettes, pouches, hookahs and e-cigarettes, to protect youth from addiction and disease.

30 May 2025

Traditional Kava rituals provide alternative pathway to PTSD recovery

Researchers reviewed pilot and qualitative evidence suggesting that combining traditional Pacific kava with talanoa dialogue may help reduce PTSD symptoms among Pacific veterans and first responders. A clinical trial is planned to formally evaluate the safety, efficacy, and cultural adaptability of this innovative, culturally grounded therapy.

29 May 2025